以色列iCAN首席执行官:大麻将作为高科技产业支撑国家经济发展

以色列iCAN首席执行官:大麻将作为高科技产业支撑国家经济发展

iCAN称未来5年内,全球大麻市场将飙升至330亿美元,以色列将有超过10亿美元的对外销售。新法律保证出口大麻受到严格监督,任何在该国大麻公司超过5%的外国投资都需监管机构批准。

In a long-awaited move, the Knesset, Israel's Parliament, has finally approved the export of medical cannabis allowing Israel to fully participate in the exploding cannabis industry world-wide.

以色列议会议会在期待已久的行动中终于批准了医用大麻的出口,使以色列能够充分参与世界范围内爆炸的大麻产业。

Saul Kaye, CEO of iCAN: Israel-Cannabis issued the following statement:

iCAN 首席执行官 Saul Kaye : Israel-Cannabis 发表了以下声明:

"This is a long overdue but welcome development. iCAN has been diligently working together with Israeli regulators to further the growth of the cannabis industry with the goal of having Israel become the leading global export nation of medical cannabis.

“这已经很久了,但值得欢迎。iCAN 一直努力与以色列监管机构合作,促进大麻产业的发展,目标是使以色列成为全球医用大麻出口大国。

以色列iCAN首席执行官:大麻将作为高科技产业支撑国家经济发展

"Israel, already the most advanced nation in cannabis R&D will now be able to produce and market cannabis and cannabis-based products that will help millions of people suffering from illnesses including cancer, MS, Parkinson's, sleep disorders, epilepsy, and PTSD, to name just a few.

“以色列已经是大麻研发领域最先进的国家,现在将能够生产和销售大麻和基于大麻的产品,这将帮助数百万患有癌症、 MS 、帕金森病、睡眠障碍、癫痫和创伤后应激障碍等疾病的人。


分享到:


相關文章: